Fred Hutch, UW Medicine, and Seattle Children’s formed Seattle Cancer Care Alliance (SCCA) to unite the oncology-related patient-care services of these organizations.
In doing so, they have established one of the world’s finest clinical cancer programs to:
- Accelerate the development of new knowledge of and treatment for various cancers
- Provide state-of-the-art, patient-focused cancer care
- Enhance collaborations with health-care providers in the region to raise the standard of cancer care available throughout the Pacific Northwest
- Promote and enhance the existing cancer research, teaching and clinical care programs of the Hutch, UW Medicine, and Seattle Children’s
Why SCCA was Created
SCCA was created to:
- Conduct integrated outpatient and inpatient clinical cancer services at the Hutch, University of Washington Medical Center (one of the two hospitals under the UW Medicine umbrella), and Seattle Children’s
- Operate as a multidisciplinary outpatient cancer clinic on the Hutch campus
- Develop and maintain affiliations with local, regional, and national cancer research groups and cancer care providers
SCCA is governed as a nonprofit corporation, with joint and equal representation of the Hutch, UW Medicine, and Seattle Children’s, and with a separate board of trustees with equal membership from each institution. Dr. Fred Appelbaum, director of the Hutch Clinical Research Division, is the executive director and president of SCCA. Norm Hubbard is the executive vice president of SCCA. Dr. Marc Stewart is the medical director and vice president for SCCA.
Clinical Practice Sites
SCCA patients may be seen in any one of four facilities. These include:
- State-of-the-art, specially constructed inpatient units at Seattle Children’s, which has a 38-bed pediatric hematology/oncology unit
- UW Medical Center, which has three adult hematology/oncology units with a total of 86 beds
- SCCA outpatient clinic, a seven-story, 150,000-square foot clinic on the Hutch campus. The clinic offers a comprehensive array of outpatient services for adult and pediatric patients, including bone marrow and stem cell transplantation.
- Northwest Hospital & Medical Center, home of additional SCCA Radiation Oncology services, including SCCA Proton Therapy, A ProCure Center.
- Medical oncology
- Breast cancer
- Gynecologic oncology
- Transplant services
- Allogeneic marrow and stem cell
- Autologous marrow and stem cell
- Long-term follow-up service
- Infusion therapy
- Conventional radiation therapy
Other Patient Care
- Radiology services, including computed tomography (CT) scans, magnetic resonance imaging (MRI), mammography, ultrasound, and nuclear medicine. Proton therapy will be available in 2013.
- Limited-services laboratory
- Anatomical pathology
- Minor procedures
- Social services
- Pain management
- Patient education
- Oral medicine
- Clinical laboratories, including clinical immunogenetics lab, cytogenetics lab, and molecular diagnostic lab
For inquiries about SCCA, please contact Katie Carroll or Stephany Rochon at Nyhus Communications for SCCA at (206) 323-3733 or SCCA@Nyhus.com.
Seattle Cancer Care Alliance and ProCure Treatment Centers Inc., will open a new Proton Therapy Center in north Seattle that will provide a first-of-its-kind treatment option for cancer patients throughout the Northwest. The center is scheduled to open in early 2013 on the campus of Northwest Hospital & Medical Center.